InvesT1D: Promoting Adolescent Investment in Diabetes Care

Description

The goal of this clinical trial is to see if a financial incentives program called InvesT1D is helpful to support diabetes management in adolescents with type 1 diabetes. Adolescent participants will be randomized to usual care or receive financial incentives for meeting diabetes self-management and clinical outcomes goals during the study. Researchers will compare changes in glucose levels, as well as adolescent and caregiver person-reported outcomes between groups.

Conditions

Type 1 Diabetes

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this clinical trial is to see if a financial incentives program called InvesT1D is helpful to support diabetes management in adolescents with type 1 diabetes. Adolescent participants will be randomized to usual care or receive financial incentives for meeting diabetes self-management and clinical outcomes goals during the study. Researchers will compare changes in glucose levels, as well as adolescent and caregiver person-reported outcomes between groups.

InvesT1D: Promoting Adolescent Investment in Diabetes Care

InvesT1D: Promoting Adolescent Investment in Diabetes Care

Condition
Type 1 Diabetes
Intervention / Treatment

-

Contacts and Locations

Seattle

Seattle Children's, Seattle, Washington, United States, 98105

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Diagnosed with type 1 diabetes ≥12 months
  • * Utilize a continuous glucose monitor (CGM) to support diabetes management
  • * Average daily CGM use is less than or equal to 70% of the time and/or their baseline average insulin bolus administration is less than or equal to 3 times a day
  • * Are using diabetes technology that allows for tracking of bolus insulin administration if participant wants to work on improving daily bolus insulin administration
  • * Cognitively able to participate in incentive program and complete surveys
  • * Have access to a mobile phone to receive information about goal attainment and incentive updates
  • * Have the ability to upload glucose and insulin administration data remotely per processes used by participant's diabetes care team
  • * Caregivers are willing to participate in study and complete surveys
  • * At time of screening, average CGM wear is greater than 70% of the time or baseline average insulin bolus administration is greater than 3 times a day
  • * Adolescent is not interested in using diabetes technology that allows for tracking of bolus insulin administration if participant wants to work on improving daily bolus insulin administration
  • * Cognitively or physically unable to participate
  • * Adolescent is a ward of the state
  • * Severe comorbidities including other major chronic health conditions that significantly impact daily management demands or health outcomes
  • * Caregivers are not willing to participate in study and complete surveys

Ages Eligible for Study

12 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Seattle Children's Hospital,

Study Record Dates

2027-10